Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Eli Lilly and Company
Qilu Pharmaceutical Co., Ltd.
Eli Lilly and Company
Mayo Clinic
Eli Lilly and Company
Emory University
Canadian Cancer Trials Group
AstraZeneca
Canadian Cancer Trials Group
Daiichi Sankyo
Critical Outcome Technologies Inc.
Roswell Park Cancer Institute
Scripps Health